GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transgenic Group Inc (TSE:2342) » Definitions » EV-to-FCF

Transgenic Group (TSE:2342) EV-to-FCF : (As of Dec. 15, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Transgenic Group EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Transgenic Group's Enterprise Value is 円3,574 Mil. Transgenic Group's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was 円0 Mil. Therefore, Transgenic Group's EV-to-FCF for today is .

The historical rank and industry rank for Transgenic Group's EV-to-FCF or its related term are showing as below:

TSE:2342' s EV-to-FCF Range Over the Past 10 Years
Min: -6.4   Med: 5651.28   Max: 7170.13
Current: -5.43

During the past 13 years, the highest EV-to-FCF of Transgenic Group was 7170.13. The lowest was -6.40. And the median was 5651.28.

TSE:2342's EV-to-FCF is ranked worse than
100% of 392 companies
in the Biotechnology industry
Industry Median: 8.19 vs TSE:2342: -5.43

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-15), Transgenic Group's stock price is 円190.00. Transgenic Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was 円0.180. Therefore, Transgenic Group's PE Ratio (TTM) for today is 1,055.56.


Transgenic Group EV-to-FCF Historical Data

The historical data trend for Transgenic Group's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transgenic Group EV-to-FCF Chart

Transgenic Group Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -18.02 8.98 3.54 -2.68 -5.92

Transgenic Group Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -5.92 -

Competitive Comparison of Transgenic Group's EV-to-FCF

For the Biotechnology subindustry, Transgenic Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Transgenic Group's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Transgenic Group's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Transgenic Group's EV-to-FCF falls into.



Transgenic Group EV-to-FCF Calculation

Transgenic Group's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3574.020/0
=

Transgenic Group's current Enterprise Value is 円3,574 Mil.
Transgenic Group's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Transgenic Group  (TSE:2342) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Transgenic Group's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=190.00/0.180
=1,055.56

Transgenic Group's share price for today is 円190.00.
Transgenic Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.180.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Transgenic Group EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Transgenic Group's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Transgenic Group Business Description

Traded in Other Exchanges
N/A
Address
7-1-14 Minatojimaminami-machi, Chuo-ku, Kobe-shi, JPN, 650-0047
Transgenic Group Inc formerly Trans Genic Inc is engaged in offering assistance of non-clinical experiments using large animals and general rearing management work, and non-clinical trial service using large animals.

Transgenic Group Headlines

No Headlines